ECSP961746A - Sal de pirrolidinil, metil indol - Google Patents

Sal de pirrolidinil, metil indol

Info

Publication number
ECSP961746A
ECSP961746A ECSP961746A ECSP961746A EC SP961746 A ECSP961746 A EC SP961746A EC SP961746 A ECSP961746 A EC SP961746A EC SP961746 A ECSP961746 A EC SP961746A
Authority
EC
Ecuador
Prior art keywords
pyrolidinyl
salt
methyl indol
indol
methyl
Prior art date
Application number
Other languages
English (en)
Inventor
Martin James Wythes
Phillip D Perry
Roland Pimm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961746 priority Critical patent/ECSP961746A/es
Publication of ECSP961746A publication Critical patent/ECSP961746A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

El invento se refiere a la sal fumarato de ®-5-(metilaminosulfonilmetil)-3-(N-metilpirrolidin-2-ilmetil)-1H-indol, útil en el tratamiento de la migraña (gráfico).
ECSP961746 1996-05-16 1996-05-16 Sal de pirrolidinil, metil indol ECSP961746A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961746 ECSP961746A (es) 1996-05-16 1996-05-16 Sal de pirrolidinil, metil indol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961746 ECSP961746A (es) 1996-05-16 1996-05-16 Sal de pirrolidinil, metil indol

Publications (1)

Publication Number Publication Date
ECSP961746A true ECSP961746A (es) 1997-09-22

Family

ID=42042476

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961746 ECSP961746A (es) 1996-05-16 1996-05-16 Sal de pirrolidinil, metil indol

Country Status (1)

Country Link
EC (1) ECSP961746A (es)

Similar Documents

Publication Publication Date Title
FI954944A0 (fi) Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon
WO2007030559A3 (en) 1, 3-disubstituted indole derivatives for use as ppar modulators
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
ATE415979T1 (de) Behandlung mit anti-erbb2 antikörpern
TR200102021T2 (tr) TWEAK ve TWEAK reseptörü antagonistleri ve bunların imünolojik bozuklukların iyileştirilmesi için kullanımları
GB2387696A (en) Real-time odds-based gaming
DK0951282T3 (da) Forebyggelse og behandling af skeletlidelse med EP2-receptorsubtype-selektive prostaglandin E2-agonister
NO20032762L (no) Aktivitetsstyringsanordning
IS2253B (is) Notkun á eletriptani til fyrirbyggingar á endurteknu mígreni
DE69912743D1 (de) Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
ATE422885T1 (de) Cycloalkyläbü kondensierte indole
DE59510131D1 (de) Imidazopyridin-azolidinone
AR035406A1 (es) Procedimiento de preparacion de eletriptan
YU29496A (sh) So pirolidinil metil indola
NO20005548D0 (no) Mykobakterieinhibitorer
EA200000909A1 (ru) ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА
TR200002939T2 (tr) Paroksetin maleat
ATE406880T1 (de) Behandlung von motorischen veränderungen mit 5- hydrxoytryptamin 1a rezeptor aktivität verstärkenden wirkstoffen
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
JP2002511904A5 (es)
FI973382A0 (fi) Migreenin hoitoon käytettävä indolijohdannainen
NL1006014A1 (nl) Zuurmakend additief met vertraagde werking voor diervoeding en werkwijzen voor toepassing daarvan.
HK1120800A (en) 1,3-disubstituted indole derivatives for use as ppar modulators
UA33864A (uk) Кардіотонічний засіб суфан у вигляді супозиторіїв